Skip to main content
. 2022 Jan 28;13(2):1124–1133. doi: 10.1002/jcsm.12918

Table 1.

Descriptive characteristics

Mean (SD) or N (%) CON CWS CWL P value
N = 26 N = 47 N = 27
Age (years) 65.0 (8.2) 63.6 (9.0) 66.0 (8.0) 0.52
Ht (cm) 176.2 (6.0) 177.3 (7.5) 177.1 (9.7) 0.84
Wt (kg) 93.6 (16.7) 97.9 (20.7)* 82.9 (22.9) 0.01
BMI (kg/m2) 30.2 (5.4) 31.0 (5.5)* 26.4 (6.0) 0.003
6‐mo Wt change (%) −2.4 (2.2)* −0.6 (2.3)* −8.7 (5.9) <0.001
Ethnicity 0.81
White, non‐Hispanic 19 (73.1) 30 (63.8) 23 (85.2)
White, Hispanic 0 (0.0) 3 (6.4) 1 (3.7)
Black, non‐Hispanic 5 (19.2) 6 (12.8) 2 (7.4)
Asian, Pacific Islander 1 (2.2) 3 (6.4) 1 (3.7)
Native American 0 (0.0) 2 (4.3) 0 (0.0)
Multiple 0 (0.0) 2 (4.3) 0 (0.0)
Unknown/declined 1 (2.2) 1 (2.1) 0 (0.0)
Tumour 0.47
Gastrointestinal 19 (40.4) 14 (51.9)
Genitourinary 28 (59.6) 13 (48.1)
Stage 0.28
1/2 37 (78.7) 18 (66.7)
3/4 10 (21.3) 9 (33.3)
Prior 3 month chemo (y) 6 (12.8) 6 (22.2) 0.34
Prior 3 month rads (y) 4 (8.5) 4 (14.8) 0.45

CON, non‐cancer control patients; CWS, weight‐stable cancer patients; CWL, cancer patients with weight loss; BMI, body mass index; chemo, chemotherapy exposure; rads, radiation exposure; y, yes. P values were derived from one‐way ANOVA with Tukey's post‐hoc pairwise comparison for continuous variables or from Fisher's exact test for categorical variables.

*

vs. CWL, P ≤ 0.05.